comparemela.com
Home
Live Updates
Joint Deployment Formulary - Breaking News
Pages:
Latest Breaking News On - Joint deployment formulary - Page 1 : comparemela.com
AcelRx Pharmaceuticals, Inc (ACRX) Q3 2022 Results - Earnings Call Transcript
AcelRx Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ACRX) Q3 2022 Results Earnings Conference Call November 14, 2022, 04:30 PM ET Company Participants Raffi Asadorian - Chief Financial Officer.
United states
South korea
Ed arce
Pam palmer
Vince angotti
Pamela palmer
Vincent angotti
Raffi asadorian
Stuart goldstein
Lakhmir chawla
Thomas lee
Brandon folkes
Company participants
Us navy
Us air
Department of defense
AcelRx Pharmaceuticals (ACRX) CEO Vincent Angotti Details Near Term Revenue Prospects
Interview with Vincent Angotti CEO and a member of the board of directors at AcelRx Pharmaceuticals (ACRX).
New york
United states
Columbia university
Cornell university
Harvard brigham
Vincent angotti
Us department of defense
Xenoport inc
Department of defense
Acelrx pharmaceuticals
Montefiore medical center
Acelrx pharmaceuticals inc
Reliant pharmaceuticals
Angotti details near term revenue
Senior vice president
Wall street transcript
vimarsana © 2020. All Rights Reserved.